However, studies evaluating the putative tumor suppressive biological and clinical impact of NDRG2 in breast cancer were irrespective of intrinsic breast cancer subtypes or as mentioned in this study before, mainly based on luminal- and basal B-type cell models. The gene discussed is NDRG2; the disease is breast cancer.